$CMPO
CompoSecure, Inc. Stock $cmpo

$cmpo Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000182314423000006 Filed on March 10, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$93.79M	$378.5M
YoY Change	-65.0%	41.25%
Cost Of Revenue	$43.51M	$158.8M
YoY Change	-64.65%	29.03%
Gross Profit	$50.28M	$219.6M
YoY Change	-65.29%	51.64%
Gross Profit Margin	53.6%	58.03%
Selling, General & Admin	$25.42M	$116.6M
YoY Change	-59.91%	83.77%
% of Gross Profit	50.57%	53.07%
Research & Development		$6.723M
YoY Change		148.91%
% of Gross Profit		3.06%
Depreciation & Amortization	$1.998M	$8.575M
YoY Change	-80.84%	-17.77%
% of Gross Profit	3.97%	3.9%
Operating Expenses	$25.42M	$116.6M
YoY Change	-57.69%	83.77%
Operating Profit	$24.85M	$114.9M
YoY Change	-70.68%	41.11%
Interest Expense	-$6.101M	-$20.13M
YoY Change	124.42%	96.67%
% of Operating Profit	-24.55%	-17.52%
Other Income/Expense, Net	$4.228M	$21.28M
YoY Change	-67.63%	1779.86%
Pretax Income	$22.98M	$136.2M
YoY Change	88.25%	64.95%
Income Tax	$622.0K	$4.360M
% Of Pretax Income	2.71%	3.2%
Net Earnings	$3.171M	$18.66M
YoY Change	-87.83%	38.08%
Net Earnings / Revenue	3.38%	4.93%
Basic Earnings Per Share		$1.21
Diluted Earnings Per Share	$0.10	$1.13
COMMON SHARES
Basic Shares Outstanding		15.37M shares
Diluted Shares Outstanding		32.56M shares

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.64M	$13.64M
YoY Change	-37.83%	-37.83%
Cash & Equivalents	$13.64M
Short-Term Investments
Other Short-Term Assets	$3.824M	$3.824M
YoY Change	47.3%	47.3%
Inventory	$42.37M	$42.37M
Prepaid Expenses
Receivables	$37.27M	$37.27M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$97.11M	$97.11M
YoY Change	24.07%	24.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.66M	$31.59M
YoY Change	2.16%	15.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$34.24M	$34.24M
YoY Change	33.45%	33.45%
Total Long-Term Assets	$65.83M	$65.83M
YoY Change	24.02%	24.02%
TOTAL ASSETS
Total Short-Term Assets	$97.11M	$97.11M
Total Long-Term Assets	$65.83M	$65.83M
Total Assets	$162.9M	$162.9M
YoY Change	24.05%	24.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.127M	$7.127M
YoY Change	0.98%	0.98%
Accrued Expenses	$10.15M	$23.49M
YoY Change	-23.19%	31.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$14.37M	$14.37M
YoY Change	14.98%	14.98%
Total Short-Term Liabilities	$44.99M	$44.99M
YoY Change	-25.65%	-25.65%
LONG-TERM LIABILITIES
Long-Term Debt	$343.6M	$343.6M
YoY Change	-8.37%	-8.37%
Other Long-Term Liabilities	$66.32M	$66.32M
YoY Change		-35.89%
Total Long-Term Liabilities	$409.9M	$409.9M
YoY Change		-14.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.99M	$44.99M
Total Long-Term Liabilities	$409.9M	$409.9M
Total Liabilities	$454.9M	$1.055B
YoY Change	-15.6%	-8.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$924.6M
YoY Change	-10.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$892.2M	-$892.2M
YoY Change
Total Liabilities & Shareholders Equity	$162.9M	$162.9M
YoY Change	24.05%	24.05%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$3.171M	$18.66M
YoY Change	-87.83%	38.08%
Depreciation, Depletion And Amortization	$1.998M	$8.575M
YoY Change	-80.84%	-17.77%
Cash From Operating Activities	$1.932M	$92.78M
YoY Change	-97.54%	19.29%
INVESTING ACTIVITIES
Capital Expenditures	$1.832M	$9.053M
YoY Change	-138.6%	90.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.832M	-$9.053M
YoY Change	-61.4%	90.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.888M	-$92.03M
YoY Change	-97.08%	42.66%
NET CHANGE
Cash From Operating Activities	1.932M	$92.78M
Cash From Investing Activities	-1.832M	-$9.053M
Cash From Financing Activities	-1.888M	-$92.03M
Net Change In Cash	-1.788M	-$8.302M
YoY Change	-119.63%	-197.42%
FREE CASH FLOW
Cash From Operating Activities	$1.932M	$92.78M
Capital Expenditures	$1.832M	$9.053M
Free Cash Flow	$100.0K	$83.73M
YoY Change	-99.88%	14.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001823144
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39687
CY2022	dei	Entity Registrant Name EntityRegistrantName	CompoSecure, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2749902
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	309 Pierce Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Somerset
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08873
CY2022	dei	City Area Code CityAreaCode	908
CY2022	dei	Local Phone Number LocalPhoneNumber	518-0500
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	48200000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2149000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1205000	usd
CY2022	dei	Auditor Firm AuditorFirmId	248
CY2022	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2022	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13642000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21944000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37272000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27925000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	42374000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	25806000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3824000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2596000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	97112000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	78271000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22655000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22177000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8932000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5246000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	25569000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	25650000	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	8651000	usd
CY2021Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	0	usd
CY2022Q4	cmpo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	24000	usd
CY2021Q4	cmpo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	10000	usd
CY2022Q4	us-gaap	Assets Assets	162943000	usd
CY2021Q4	us-gaap	Assets Assets	131354000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14372000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12500000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1846000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1119000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7127000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7058000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10154000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10131000	usd
CY2022Q4	cmpo	Deferred Issuance Costs Current DeferredIssuanceCostsCurrent	0	usd
CY2021Q4	cmpo	Deferred Issuance Costs Current DeferredIssuanceCostsCurrent	23107000	usd
CY2022Q4	cmpo	Commission Payable Current CommissionPayableCurrent	3317000	usd
CY2021Q4	cmpo	Commission Payable Current CommissionPayableCurrent	3089000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	8177000	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3512000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44993000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60516000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	216276000	usd
CY2021Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	233132000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	127348000	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	126897000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	285000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	552000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	16341000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	35271000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7766000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4709000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	26842000	usd
CY2021Q4	cmpo	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	24500000	usd
CY2022Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	15090000	usd
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	38427000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	454941000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	539004000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	600234000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	608311000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24107000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12261000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8283000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-924630000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1028229000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-892232000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015961000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	162943000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	131354000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378476000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	267948000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	260586000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	158832000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	123099000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	127959000	usd
CY2022	us-gaap	Gross Profit GrossProfit	219644000	usd
CY2021	us-gaap	Gross Profit GrossProfit	144849000	usd
CY2020	us-gaap	Gross Profit GrossProfit	132627000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104749000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63424000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48669000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	114895000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	81425000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	83958000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-18930000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3485000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	23337000	usd
CY2021	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	9575000	usd
CY2020	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	266000	usd
CY2021	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1249000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	52000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20129000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-10235000	usd
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-5266000	usd
CY2022	cmpo	Amortization Of Debt Issuance Costs And Other Fees AmortizationOfDebtIssuanceCostsAndOtherFees	2415000	usd
CY2021	cmpo	Amortization Of Debt Issuance Costs And Other Fees AmortizationOfDebtIssuanceCostsAndOtherFees	1693000	usd
CY2020	cmpo	Amortization Of Debt Issuance Costs And Other Fees AmortizationOfDebtIssuanceCostsAndOtherFees	877000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1291000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21280000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1132000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6143000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	136175000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	82557000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	77815000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4360000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-857000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Profit Loss ProfitLoss	131815000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	83414000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	77815000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	113158000	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	80260000	usd
CY2020	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	18657000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3154000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	77815000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15372000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14930000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32555000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94570000	shares
CY2022	us-gaap	Profit Loss ProfitLoss	131815000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	83414000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	77815000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	8283000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8283000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	140098000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	83414000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	77815000	usd
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-55549000	usd
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2020	us-gaap	Dividends Dividends	216668000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1848000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	77815000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-192554000	usd
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021	us-gaap	Dividends Dividends	226643000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-77980000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6113000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3154000	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	80260000	usd
CY2021	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-528051000	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	528051000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015961000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	608311000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	36293000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11465000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-726000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	18657000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	113158000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	76000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8283000	usd
CY2022	cmpo	Adjustments To Paid In Capital Tax Receivable Agreement Liability AdjustmentsToPaidInCapitalTaxReceivableAgreementLiability	1025000	usd
CY2022	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	84942000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-84942000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-892232000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	600234000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	131815000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	83414000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	77815000	usd
CY2022	us-gaap	Depreciation Depreciation	8575000	usd
CY2021	us-gaap	Depreciation Depreciation	10428000	usd
CY2020	us-gaap	Depreciation Depreciation	9916000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	11465000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	6113000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1848000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1668000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	600000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	1157000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2345000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1654000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	842000	usd
CY2022	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	23337000	usd
CY2021	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	9575000	usd
CY2020	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-18930000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3485000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	266000	usd
CY2021	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3193000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-857000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9347000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19133000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10249000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18237000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3792000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12866000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1228000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1519000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	94000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	68000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4637000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-456000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	23000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1665000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	332000	usd
CY2022	cmpo	Increase Decrease In Deposit And Other Assets IncreaseDecreaseInDepositAndOtherAssets	14000	usd
CY2021	cmpo	Increase Decrease In Deposit And Other Assets IncreaseDecreaseInDepositAndOtherAssets	0	usd
CY2020	cmpo	Increase Decrease In Deposit And Other Assets IncreaseDecreaseInDepositAndOtherAssets	0	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4990000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	46000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1681000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	92783000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77780000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	87062000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9053000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4746000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7501000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9053000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4746000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7501000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	60826000	usd
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	82000	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	127400000	usd
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5000000	usd
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	117500000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	16878000	usd
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	240000000	usd
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	10500000	usd
CY2022	cmpo	Payment Of Tax Receivable Agreement Liability PaymentOfTaxReceivableAgreementLiability	110000	usd
CY2021	cmpo	Payment Of Tax Receivable Agreement Liability PaymentOfTaxReceivableAgreementLiability	0	usd
CY2020	cmpo	Payment Of Tax Receivable Agreement Liability PaymentOfTaxReceivableAgreementLiability	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1860000	usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3199000	usd
CY2022	cmpo	Payment Of Distributions Recapitalization PaymentOfDistributionsRecapitalization	0	usd
CY2021	cmpo	Payment Of Distributions Recapitalization PaymentOfDistributionsRecapitalization	218300000	usd
CY2020	cmpo	Payment Of Distributions Recapitalization PaymentOfDistributionsRecapitalization	0	usd
CY2022	cmpo	Payment Of Distributions To Members PaymentOfDistributionsToMembers	36293000	usd
CY2021	cmpo	Payment Of Distributions To Members PaymentOfDistributionsToMembers	22334000	usd
CY2020	cmpo	Payment Of Distributions To Members PaymentOfDistributionsToMembers	216668000	usd
CY2022	cmpo	Payment Of Issuance Costs Recapitalization PaymentOfIssuanceCostsRecapitalization	23833000	usd
CY2021	cmpo	Payment Of Issuance Costs Recapitalization PaymentOfIssuanceCostsRecapitalization	15244000	usd
CY2020	cmpo	Payment Of Issuance Costs Recapitalization PaymentOfIssuanceCostsRecapitalization	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-92032000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-64512000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-92867000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8302000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8522000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13306000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21944000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13422000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26728000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13642000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21944000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13422000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	21379000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	10101000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	5317000	usd
CY2022	cmpo	Noncash Change In Derivative Asset NoncashChangeInDerivativeAsset	8651000	usd
CY2021	cmpo	Noncash Change In Derivative Asset NoncashChangeInDerivativeAsset	0	usd
CY2020	cmpo	Noncash Change In Derivative Asset NoncashChangeInDerivativeAsset	0	usd
CY2022	cmpo	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	0	usd
CY2021	cmpo	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	23107000	usd
CY2020	cmpo	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain reclassifications have been made to conform to the current year presentation.
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain reclassifications have been made to conform to the current year presentation.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	The preparation of the consolidated financial statements requires management to make a number of estimates and assumptions relating to the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. The Company bases its estimates on historical experience, current business factors and various other assumptions believed to be reasonable under the circumstances, all of which are necessary in order to form a basis for determining the carrying values of assets and liabilities. Actual results may differ from those estimates and assumptions. The Company evaluates the adequacy of its reserves and the estimates used in calculations on an on-going basis. Significant areas requiring management to make estimates include the valuation of equity instruments, measurement of changes in the fair value of earnout consideration liability, estimates of derivative liability associated with the exchangeable notes due December 2026, which will be marked to market each quarter based on a Lattice model approach, changes in the fair value of warrant liabilities, derivative asset for the interest rate swap, valuation allowances on deferred tax assets which are based on an assessment of recoverability of the deferred tax assets against future taxable income and estimates of the inputs used to calculate the tax receivable agreement liability.
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022	us-gaap	Selling Expense SellingExpense	11808000	usd
CY2021	us-gaap	Selling Expense SellingExpense	17434000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022	cmpo	Revenue Performance Obligation Payment Terms Minimum RevenuePerformanceObligationPaymentTermsMinimum	P15D
CY2022	cmpo	Revenue Performance Obligation Payment Terms Maximum RevenuePerformanceObligationPaymentTermsMaximum	P60D
CY2022	cmpo	Revenue Performance Obligation Payment Due RevenuePerformanceObligationPaymentDue	P90D
CY2022	cmpo	Shipping And Handling Costs ShippingAndHandlingCosts	2755000	usd
CY2021	cmpo	Shipping And Handling Costs ShippingAndHandlingCosts	2308000	usd
CY2020	cmpo	Shipping And Handling Costs ShippingAndHandlingCosts	1596000	usd
CY2020	us-gaap	Selling Expense SellingExpense	181000	usd
CY2022	cmpo	Proceeds From Tax Distributions ProceedsFromTaxDistributions	8141000	usd
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	7500000	shares
CY2021Q4	cmpo	Tax Receivable Agreement Percentage TaxReceivableAgreementPercentage	0.90
CY2022Q4	cmpo	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	26842000	usd
CY2021Q4	cmpo	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	24500000	usd
CY2022	cmpo	Payment Of Tax Receivable Agreement Liability PaymentOfTaxReceivableAgreementLiability	110000	usd
CY2022	cmpo	Salaries And Commissions SalariesAndCommissions	35650000	usd
CY2021	cmpo	Salaries And Commissions SalariesAndCommissions	16103000	usd
CY2020	cmpo	Salaries And Commissions SalariesAndCommissions	12650000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	14024000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	11134000	usd
CY2020	us-gaap	Professional Fees ProfessionalFees	6800000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that potentially subject the Company to credit risk consist principally of investments in cash, cash equivalents, short-term investments and accounts receivable. The Company’s primary exposure is credit risk on receivables as the Company does not require any collateral for its accounts receivable. Credit risk is the loss that may result from a trade customer’s or counterparty’s nonperformance. The Company uses credit policies to control credit risk, including utilizing an established credit approval process, monitoring customer and counterparty limits, monitoring changes in a customer’s credit rating, employing credit mitigation measures such as analyzing customers’ financial statements, and accepting personal guarantees and various forms of collateral. The Company believes that its customers and counterparties will be able to satisfy their obligations under their contracts.The Company maintains cash, cash equivalents with approved federally insured financial institutions. Such deposit accounts at times may exceed federally insured limits. The Company is exposed to credit risks and liquidity in the event of default by the financial institutions or issuers of investments in excess of FDIC insured limits. The Company performs periodic evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any institution if required.
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	7500000	shares
CY2021Q4	cmpo	Tax Receivable Agreement Percentage TaxReceivableAgreementPercentage	0.90
CY2021Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4500000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q4	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	45000000	usd
CY2021Q4	cmpo	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	47359000	usd
CY2021Q4	cmpo	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	34132000	usd
CY2021Q4	cmpo	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	188226000	usd
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4500000	shares
CY2021Q4	cmpo	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	14929982	shares
CY2021Q4	cmpo	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	61136800	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76066782	shares
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	43313000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	27474000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2892000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	582000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	450000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	363000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4281000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2613000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	42374000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	25806000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	85866000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	76813000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63211000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54636000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22655000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22177000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8575000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10428000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9916000	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	266000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	14188000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	11928000	usd
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	6142000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	363122000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	380000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14372000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12500000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-5126000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-7471000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	343624000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	360029000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	285000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	552000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	14372000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	18750000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	130000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	363122000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	400000	usd
CY2022	cmpo	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	gain upon the settlement
CY2022Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	125000000	usd
CY2022Q1	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2022Q2	cmpo	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	renewal_option
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P3Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0384
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8932000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5246000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1846000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1119000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7766000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4709000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1854000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1305000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	653000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	444000	usd
CY2022	us-gaap	Lease Cost LeaseCost	2507000	usd
CY2021	us-gaap	Lease Cost LeaseCost	1749000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2149000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2146000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2176000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1882000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	912000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1205000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10470000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	858000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9612000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1700000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1272000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5104000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11465000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6113000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1848000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0209
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0214
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.6759
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7030
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	cmpo	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9778	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6823006	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1413235	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5409771	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	644226	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4765545	shares
CY2021Q4	cmpo	Reverse Recapitalization Number Of Grantees Affected By Recapitalization ReverseRecapitalizationNumberOfGranteesAffectedByRecapitalization	12	grantee
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	7500000	shares
CY2022Q4	cmpo	Share Based Compensation Arrangement By Share Based Payment Awards Contingent Consideration Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardsContingentConsiderationShares	657160	shares
CY2022Q4	cmpo	Share Based Compensation Arrangement By Share Based Payment Awards Contingent Consideration Shares Per Phase ShareBasedCompensationArrangementByShareBasedPaymentAwardsContingentConsiderationSharesPerPhase	328580	shares
CY2021Q4	cmpo	Share Based Compensation Arrangement By Share Based Payment Awards Contingent Consideration Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardsContingentConsiderationShares	657160	shares
CY2021Q4	cmpo	Share Based Compensation Arrangement By Share Based Payment Awards Contingent Consideration Shares Per Phase ShareBasedCompensationArrangementByShareBasedPaymentAwardsContingentConsiderationSharesPerPhase	328580	shares
CY2021Q4	cmpo	Share Based Compensation Arrangement By Share Based Payment Awards Contingent Consideration Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardsContingentConsiderationIntrinsicValue	5395000	usd
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4400
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0107
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	cmpo	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5409771	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.27
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1614000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	37542000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	644226	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3180000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4765545	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.44
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16939000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4765545	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.44
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	16939000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4616197	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.29
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M6D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16923000	usd
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.36
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4616197	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4947921	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5894922	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.29
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.26
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	406.63
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	308000	usd
CY2022	cmpo	Defined Contribution Plan Requisite Service Period DefinedContributionPlanRequisiteServicePeriod	P90D
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1102000	usd
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1030000	usd
CY2022	cmpo	Deferred Compensation Arrangement With Individual Percent Of Ebitda Contributed DeferredCompensationArrangementWithIndividualPercentOfEBITDAContributed	0.0025
CY2022Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	242000	usd
CY2021Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	242000	usd
CY2022	cmpo	Deferred Compensation Arrangement With Individual Vesting Period DeferredCompensationArrangementWithIndividualVestingPeriod	P7Y
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year One DeferredCompensationArrangementWithIndividualVestingPercentageYearOne	0.000
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year Two DeferredCompensationArrangementWithIndividualVestingPercentageYearTwo	0.050
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year Three DeferredCompensationArrangementWithIndividualVestingPercentageYearThree	0.150
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year Four DeferredCompensationArrangementWithIndividualVestingPercentageYearFour	0.200
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year Five DeferredCompensationArrangementWithIndividualVestingPercentageYearFive	0.300
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year Six DeferredCompensationArrangementWithIndividualVestingPercentageYearSix	0.500
CY2022Q4	cmpo	Deferred Compensation Arrangement With Individual Vesting Percentage Year Seven DeferredCompensationArrangementWithIndividualVestingPercentageYearSeven	1
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	8651000	usd
CY2022Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	15090000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	285000	usd
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	38427000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	552000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	38756000	usd
CY2021Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3485000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	35271000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-18930000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-857000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	16341000	usd
CY2022Q4	us-gaap	Share Price SharePrice	4.91
CY2021Q4	us-gaap	Share Price SharePrice	8.21
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	7500000	shares
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	48002000	usd
CY2021Q4	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	9575000	usd
CY2021Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	38427000	usd
CY2022	cmpo	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	23337000	usd
CY2022Q4	cmpo	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	15090000	usd
CY2022Q4	us-gaap	Share Price SharePrice	4.91
CY2021Q4	us-gaap	Share Price SharePrice	8.21
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378476000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	267948000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	260586000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4360000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-857000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	136175000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	82557000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	77815000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12206000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1140000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	27000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1167000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3477000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-856000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-284000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3193000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-857000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4360000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0320
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0028
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0111
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.1752
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.1853
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0064
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0335
CY2022	cmpo	Effective Income Tax Rate Reconciliation Other Comprehensive Income Adjustment Percent EffectiveIncomeTaxRateReconciliationOtherComprehensiveIncomeAdjustmentPercent	-0.0027
CY2021	cmpo	Effective Income Tax Rate Reconciliation Other Comprehensive Income Adjustment Percent EffectiveIncomeTaxRateReconciliationOtherComprehensiveIncomeAdjustmentPercent	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0076
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	25569000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0085
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	32256000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	29102000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	686000	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	623000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	970000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	819000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	32942000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31514000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7373000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5864000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	25650000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7373000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1509000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	cmpo	Cares Act Employee Retention Credit CARESActEmployeeRetentionCredit	1291000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	131815000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	83414000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	113158000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	80260000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18657000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3154000	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	18017000	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	7943000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	36674000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11097000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15372422	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14929982	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	17182895	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	79639876	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32555317	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94569858	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18657000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15372422	shares
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	36674000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32555317	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3154000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14929982	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11097000	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94569858	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3154000	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	80260000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability To Be Paid Year One TaxReceivableAgreementLiabilityToBePaidYearOne	2367000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability To Be Paid Year Two TaxReceivableAgreementLiabilityToBePaidYearTwo	1417000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability To Be Paid Year Three TaxReceivableAgreementLiabilityToBePaidYearThree	1431000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability To Be Paid Year Four TaxReceivableAgreementLiabilityToBePaidYearFour	1460000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability To Be Paid Year Five TaxReceivableAgreementLiabilityToBePaidYearFive	1491000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability To Be Paid After Year Five TaxReceivableAgreementLiabilityToBePaidAfterYearFive	18676000	usd
CY2022Q4	cmpo	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	26842000	usd
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	21959000	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	9508000	usd
CY2020	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	6724000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3317000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3402000	usd

Files In Submission

Name	View Source	Status
cmpo-20221231_cal.xml	Edgar Link	unprocessable
cmpo-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001823144-23-000006-index-headers.html	Edgar Link	pending
0001823144-23-000006-index.html	Edgar Link	pending
0001823144-23-000006.txt	Edgar Link	pending
0001823144-23-000006-xbrl.zip	Edgar Link	pending
cmpo-20221231.htm	Edgar Link	pending
cmpo-20221231.xsd	Edgar Link	pending
cmpo-20221231_g1.jpg	Edgar Link	pending
cmpo-20221231_g2.jpg	Edgar Link	pending
exhibit1035-jpmc_compose.htm	Edgar Link	pending
exhibit1035-jpmc_compose001.jpg	Edgar Link	pending
exhibit1035-jpmc_compose002.jpg	Edgar Link	pending
exhibit1035-jpmc_compose003.jpg	Edgar Link	pending
exhibit1035-jpmc_compose004.jpg	Edgar Link	pending
exhibit1035-jpmc_compose005.jpg	Edgar Link	pending
exhibit1035-jpmc_compose006.jpg	Edgar Link	pending
exhibit1035-jpmc_compose007.jpg	Edgar Link	pending
exhibit1035-jpmc_compose008.jpg	Edgar Link	pending
exhibit1035-jpmc_compose009.jpg	Edgar Link	pending
exhibit1035-jpmc_compose010.jpg	Edgar Link	pending
exhibit1035-jpmc_compose011.jpg	Edgar Link	pending
exhibit1035-jpmc_compose012.jpg	Edgar Link	pending
exhibit1035-jpmc_compose013.jpg	Edgar Link	pending
exhibit1035-jpmc_compose014.jpg	Edgar Link	pending
exhibit1035-jpmc_compose015.jpg	Edgar Link	pending
exhibit1035-jpmc_compose016.jpg	Edgar Link	pending
exhibit1035-jpmc_compose017.jpg	Edgar Link	pending
exhibit1035-jpmc_compose018.jpg	Edgar Link	pending
exhibit1035-jpmc_compose019.jpg	Edgar Link	pending
exhibit1035-jpmc_compose020.jpg	Edgar Link	pending
exhibit1035-jpmc_compose021.jpg	Edgar Link	pending
exhibit1035-jpmc_compose022.jpg	Edgar Link	pending
exhibit1035-jpmc_compose023.jpg	Edgar Link	pending
exhibit1035-jpmc_compose024.jpg	Edgar Link	pending
exhibit1035-jpmc_compose025.jpg	Edgar Link	pending
exhibit1035-jpmc_compose026.jpg	Edgar Link	pending
exhibit1035-jpmc_compose027.jpg	Edgar Link	pending
exhibit1035-jpmc_compose028.jpg	Edgar Link	pending
exhibit1035-jpmc_compose029.jpg	Edgar Link	pending
exhibit1035-jpmc_compose030.jpg	Edgar Link	pending
exhibit1035-jpmc_compose031.jpg	Edgar Link	pending
exhibit1035-jpmc_compose032.jpg	Edgar Link	pending
exhibit1035-jpmc_compose033.jpg	Edgar Link	pending
exhibit1035-jpmc_compose034.jpg	Edgar Link	pending
exhibit1035-jpmc_compose035.jpg	Edgar Link	pending
exhibit1035-jpmc_compose036.jpg	Edgar Link	pending
cmpo-20221231_def.xml	Edgar Link	unprocessable
cmpo-20221231_lab.xml	Edgar Link	unprocessable
cmpo-20221231_htm.xml	Edgar Link	completed
exhibit1035-jpmc_compose037.jpg	Edgar Link	pending
exhibit1035-jpmc_compose038.jpg	Edgar Link	pending
exhibit1035-jpmc_compose039.jpg	Edgar Link	pending
exhibit1035-jpmc_compose040.jpg	Edgar Link	pending
exhibit1035-jpmc_compose041.jpg	Edgar Link	pending
exhibit1035-jpmc_compose042.jpg	Edgar Link	pending
exhibit1035-jpmc_compose043.jpg	Edgar Link	pending
exhibit1035-jpmc_compose044.jpg	Edgar Link	pending
exhibit1035-jpmc_compose045.jpg	Edgar Link	pending
exhibit1035-jpmc_compose046.jpg	Edgar Link	pending
exhibit1035-jpmc_compose047.jpg	Edgar Link	pending
exhibit1035-jpmc_compose048.jpg	Edgar Link	pending
exhibit1035-jpmc_compose049.jpg	Edgar Link	pending
exhibit1035-jpmc_compose050.jpg	Edgar Link	pending
exhibit1035-jpmc_compose051.jpg	Edgar Link	pending
exhibit1035-jpmc_compose052.jpg	Edgar Link	pending
exhibit1035-jpmc_compose053.jpg	Edgar Link	pending
exhibit1035-jpmc_compose054.jpg	Edgar Link	pending
exhibit1035-jpmc_compose055.jpg	Edgar Link	pending
exhibit1035-jpmc_compose056.jpg	Edgar Link	pending
exhibit1035-jpmc_compose057.jpg	Edgar Link	pending
exhibit1035-jpmc_compose058.jpg	Edgar Link	pending
exhibit1035-jpmc_compose059.jpg	Edgar Link	pending
exhibit1035-jpmc_compose060.jpg	Edgar Link	pending
exhibit1035-jpmc_compose061.jpg	Edgar Link	pending
exhibit1035-jpmc_compose062.jpg	Edgar Link	pending
exhibit1035-jpmc_compose063.jpg	Edgar Link	pending
exhibit1035-jpmc_compose064.jpg	Edgar Link	pending
exhibit1035-jpmc_compose065.jpg	Edgar Link	pending
exhibit1035-jpmc_compose066.jpg	Edgar Link	pending
exhibit1035-jpmc_compose067.jpg	Edgar Link	pending
exhibit1035-jpmc_compose068.jpg	Edgar Link	pending
exhibit1035-jpmc_compose069.jpg	Edgar Link	pending
exhibit1035-jpmc_compose070.jpg	Edgar Link	pending
exhibit1035-jpmc_compose071.jpg	Edgar Link	pending
exhibit1035-jpmc_compose072.jpg	Edgar Link	pending
exhibit1035-jpmc_compose073.jpg	Edgar Link	pending
exhibit1035-jpmc_compose074.jpg	Edgar Link	pending
exhibit1035-jpmc_compose075.jpg	Edgar Link	pending
exhibit1035-jpmc_compose076.jpg	Edgar Link	pending
exhibit1035-jpmc_compose077.jpg	Edgar Link	pending
exhibit1035-jpmc_compose078.jpg	Edgar Link	pending
exhibit1035-jpmc_compose079.jpg	Edgar Link	pending
exhibit1035-jpmc_compose080.jpg	Edgar Link	pending
exhibit1035-jpmc_compose081.jpg	Edgar Link	pending
exhibit1035-jpmc_compose082.jpg	Edgar Link	pending
exhibit1035-jpmc_compose083.jpg	Edgar Link	pending
exhibit1035-jpmc_compose084.jpg	Edgar Link	pending
exhibit1035-jpmc_compose085.jpg	Edgar Link	pending
exhibit1035-jpmc_compose086.jpg	Edgar Link	pending
exhibit1035-jpmc_compose087.jpg	Edgar Link	pending
exhibit1035-jpmc_compose088.jpg	Edgar Link	pending
exhibit1035-jpmc_compose089.jpg	Edgar Link	pending
exhibit1035-jpmc_compose090.jpg	Edgar Link	pending
exhibit1035-jpmc_compose091.jpg	Edgar Link	pending
exhibit1035-jpmc_compose092.jpg	Edgar Link	pending
exhibit1035-jpmc_compose093.jpg	Edgar Link	pending
exhibit1035-jpmc_compose094.jpg	Edgar Link	pending
exhibit1035-jpmc_compose095.jpg	Edgar Link	pending
exhibit1035-jpmc_compose096.jpg	Edgar Link	pending
exhibit1035-jpmc_compose097.jpg	Edgar Link	pending
exhibit1035-jpmc_compose098.jpg	Edgar Link	pending
exhibit1035-jpmc_compose099.jpg	Edgar Link	pending
exhibit1035-jpmc_compose100.jpg	Edgar Link	pending
exhibit1035-jpmc_compose101.jpg	Edgar Link	pending
exhibit1035-jpmc_compose102.jpg	Edgar Link	pending
exhibit1035-jpmc_compose103.jpg	Edgar Link	pending
exhibit1035-jpmc_compose104.jpg	Edgar Link	pending
exhibit1035-jpmc_compose105.jpg	Edgar Link	pending
exhibit1035-jpmc_compose106.jpg	Edgar Link	pending
exhibit1035-jpmc_compose107.jpg	Edgar Link	pending
exhibit1035-jpmc_compose108.jpg	Edgar Link	pending
exhibit1035-jpmc_compose109.jpg	Edgar Link	pending
exhibit1035-jpmc_compose110.jpg	Edgar Link	pending
exhibit1035-jpmc_compose111.jpg	Edgar Link	pending
exhibit1035-jpmc_compose112.jpg	Edgar Link	pending
exhibit1035-jpmc_compose113.jpg	Edgar Link	pending
exhibit1035-jpmc_compose114.jpg	Edgar Link	pending
exhibit1035-jpmc_compose115.jpg	Edgar Link	pending
exhibit1035-jpmc_compose116.jpg	Edgar Link	pending
exhibit1035-jpmc_compose117.jpg	Edgar Link	pending
exhibit1035-jpmc_compose118.jpg	Edgar Link	pending
exhibit1035-jpmc_compose119.jpg	Edgar Link	pending
exhibit1035-jpmc_compose120.jpg	Edgar Link	pending
exhibit1035-jpmc_compose121.jpg	Edgar Link	pending
exhibit1035-jpmc_compose122.jpg	Edgar Link	pending
exhibit1035-jpmc_compose123.jpg	Edgar Link	pending
exhibit1035-jpmc_compose124.jpg	Edgar Link	pending
exhibit1035-jpmc_compose125.jpg	Edgar Link	pending
exhibit1035-jpmc_compose126.jpg	Edgar Link	pending
exhibit1035-jpmc_compose127.jpg	Edgar Link	pending
exhibit1035-jpmc_compose128.jpg	Edgar Link	pending
exhibit1035-jpmc_compose129.jpg	Edgar Link	pending
exhibit1035-jpmc_compose130.jpg	Edgar Link	pending
exhibit1035-jpmc_compose131.jpg	Edgar Link	pending
exhibit1035-jpmc_compose132.jpg	Edgar Link	pending
exhibit1035-jpmc_compose133.jpg	Edgar Link	pending
exhibit1035-jpmc_compose134.jpg	Edgar Link	pending
exhibit1035-jpmc_compose135.jpg	Edgar Link	pending
exhibit1035-jpmc_compose136.jpg	Edgar Link	pending
exhibit1035-jpmc_compose137.jpg	Edgar Link	pending
exhibit1035-jpmc_compose138.jpg	Edgar Link	pending
exhibit1035-jpmc_compose139.jpg	Edgar Link	pending
exhibit1035-jpmc_compose140.jpg	Edgar Link	pending
exhibit1035-jpmc_compose141.jpg	Edgar Link	pending
exhibit1035-jpmc_compose142.jpg	Edgar Link	pending
exhibit1035-jpmc_compose143.jpg	Edgar Link	pending
exhibit1035-jpmc_compose144.jpg	Edgar Link	pending
exhibit1035-jpmc_compose145.jpg	Edgar Link	pending
exhibit1035-jpmc_compose146.jpg	Edgar Link	pending
exhibit1035-jpmc_compose147.jpg	Edgar Link	pending
exhibit1035-jpmc_compose148.jpg	Edgar Link	pending
exhibit1035-jpmc_compose149.jpg	Edgar Link	pending
exhibit1035-jpmc_compose150.jpg	Edgar Link	pending
exhibit1035-jpmc_compose151.jpg	Edgar Link	pending
exhibit1035-jpmc_compose152.jpg	Edgar Link	pending
exhibit1035-jpmc_compose153.jpg	Edgar Link	pending
exhibit1035-jpmc_compose154.jpg	Edgar Link	pending
exhibit1035-jpmc_compose155.jpg	Edgar Link	pending
exhibit1035-jpmc_compose156.jpg	Edgar Link	pending
exhibit1035-jpmc_compose157.jpg	Edgar Link	pending
exhibit1035-jpmc_compose158.jpg	Edgar Link	pending
exhibit211-listofsubsidiar.htm	Edgar Link	pending
exhibit231-csincx10kconsent.htm	Edgar Link	pending
exhibit311-sox302certifica.htm	Edgar Link	pending
exhibit312-sox302certifica.htm	Edgar Link	pending
exhibit321-section1350cert.htm	Edgar Link	pending
exhibit322-section1350cert.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMPO
CompoSecure, Inc. Stock $cmpo

2022 Q4 Form 10-K Financial Statement

#000182314423000006 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMPO CompoSecure, Inc. Stock $cmpo

2022 Q4 Form 10-K Financial Statement

#000182314423000006 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMPO
CompoSecure, Inc. Stock $cmpo